Accessibility Menu
 
Recordati Industria Chimica E Farmaceutica S.p.A. logo

Recordati Industria Chimica E Farmaceutica S.p.A.

(OTC) RCDTF

Current Price$56.95
Market Cap$11.65B
Since IPO (2008)+631%
5 Year+21%
1 Year+5%
1 Month-13%

Recordati Industria Chimica E Farmaceutica S.p.A. Financials at a Glance

Market Cap

$11.65B

Revenue (TTM)

$2.62B

Net Income (TTM)

$443.62M

EPS (TTM)

$2.14

P/E Ratio

23.54

Dividend

$1.48

Beta (Volatility)

0.05 (Low)

Price

$56.95

Volume

166

Open

$56.95

Previous Close

$56.95

Daily Range

$56.95 - $56.95

52-Week Range

$49.00 - $65.44

RCDTF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Recordati Industria Chimica E Farmaceutica S.p.A.

Industry

Pharmaceuticals

Employees

4,583

CEO

Robert Koremans, MD

Headquarters

Milan, MI 20148, IT

RCDTF Financials

Key Financial Metrics (TTM)

Gross Margin

68%

Operating Margin

27%

Net Income Margin

17%

Return on Equity

21%

Return on Capital

17%

Return on Assets

8%

Earnings Yield

4.25%

Dividend Yield

0.03%

Payout Ratio

60.31%

Stock Overview

Market Cap

$11.65B

Shares Outstanding

204.56M

Volume

166

Short Interest

0.00%

Avg. Volume

33.694

Financials (TTM)

Gross Profit

$1.79B

Operating Income

$719.74M

EBITDA

$887.00M

Operating Cash Flow

$596.90M

Capital Expenditure

$85.12M

Free Cash Flow

$511.77M

Cash & ST Invst.

$428.82M

Total Debt

$23.85M

Recordati Industria Chimica E Farmaceutica S.p.A. Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$662.22M

+10.7%

Gross Profit

$472.65M

+14.3%

Gross Margin

71.37%

N/A

Market Cap

$11.65B

N/A

Market Cap/Employee

$2.54M

N/A

Employees

4,580

N/A

Net Income

$117.34M

+50.2%

EBITDA

$230.86M

+33.8%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$404.98M

+35.2%

Accounts Receivable

$590.05M

+8.6%

Inventory

$539.80M

+6.6%

Long Term Debt

$0.00

N/A

Short Term Debt

$23.85M

+4.4%

Return on Assets

8.45%

N/A

Return on Invested Capital

17.14%

N/A

Free Cash Flow

$145.23M

+120.8%

Operating Cash Flow

$172.57M

+49.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CHJTFCSPC Pharmaceutical Group Limited
$1.02-12.82%
ORINFOrion Oyj
$82.75+0.00%
BDULFBangkok Dusit Medical Services Public Company Limited
$0.66+0.00%
BDUUFBangkok Dusit Medical Services Public Company Limited
$0.65+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PLTRPalantir Technologies
$128.06-0.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$10.61+0.02%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$6.44-0.05%
TQQQProShares Trust - ProShares UltraPro Qqq
$49.17+0.00%

Questions About RCDTF

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.